Biotech

All Articles

Analysts explore Avidity's DMD gain, exposing distinctions in data

.Avidity Biosciences impressed investors with stage 1/2 records in Duchenne muscle dystrophy (DMD) F...

Actinogen's cortisol blocker falls short period 2 clinical depression research study

.Actinogen Medical's cortisol blocker has missed the major endpoint of a phase 2 research study in a...

Bivictrix makes a decision going personal only means to take ADC in to facility

.Antibody-drug conjugates (ADCs) have gone to the center of many a billion-dollar biobuck licensing ...

TPG tops up funds to $580M for investments across lifestyle scientific researches

.Resource supervisor TPG, which has actually sustained biotechs including Sionna Therapies and also ...

Merck ceases stage 3 TIGIT trial in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT plan has experienced yet another obstacle. Months after shuttering a period ...

After a challenging year, Exscientia folds up into Recursion

.After a year specified by pipe cuts, the shift of its CEO as well as layoffs, Exscientia will defin...

Cullinan, after $25M package, hands back bispecific to Harbour

.Cullinan Rehab was actually impressed sufficient along with Harbour BioMed's bispecific invulnerabl...

A nearer examine Tough Biotech's Tough 15

.In this particular full week's episode of "The Best Pipe," our team're diving in to Ferocious Biote...

Lilly experiences stage 2 failure of tau-targeting med

.The confetti is still soaring from Eli Lilly's party celebrating the commendation of Alzheimer's ai...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of considerable management hirings, shooting...